Corix Bioscience, Inc. (CXBS)

Corix Bioscience Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2016	FY 2015
Period Ending	Dec 31, 2016	Dec 31, 2015
Cash & Equivalents	0	0.2
Cash & Short-Term Investments	0	0.2
Cash Growth	-98.92%	-
Receivables	0	-
Total Current Assets	0	0.2
Property, Plant & Equipment	11.13	9
Total Assets	11.37	9.42
Accounts Payable	0.19	0.09
Short-Term Debt	5.08	4.27
Total Current Liabilities	5.76	4.41
Total Liabilities	5.76	4.41
Shareholders' Equity	5.61	5
Total Liabilities & Equity	11.37	9.42

Source: S&P Global Market Intelligence. Standard template. Financial Sources.